Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-08 @ 8:13 PM
Study NCT ID:
NCT02303392
Status:
COMPLETED
Last Update Posted:
2025-06-10
First Post:
2014-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
Sponsor:
Jennifer Woyach
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-25
First Submit QC Date:
None
Study First Post Date:
2014-11-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-02-13
Results First Submit QC Date:
None
Results First Post Date:
2025-06-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-22
Last Update Post Date:
2025-06-10
Last Update Post Date Type:
ACTUAL